Ribose and Sport Performance

Sports Clinical Trial

Official title:

The Effect of Ribose on Performance and Recovery in Athletes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01727479
• Other study ID #: 2012-048
• Secondary ID: INAF-2012-048
• Status: Completed
• Phase: N/A
• First received: November 2, 2012
• Last updated: December 2, 2016
• Start date: August 2012
• Est. completion date: January 2013

Study information

• Verified date: December 2016
• Source: Laval University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

Investigate the acute effect of ribose supplementation on performance and recovery in athletes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: January 2013
• Est. primary completion date: January 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Men and women

• Training volume > 7hrs/week

• VO2 max > 40 and 45 mg/kg/min (for women and men respectively)

• Otherwise healthy individuals

Exclusion Criteria:

• Pregnant or breastfeeding women

• Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia

• Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders

• Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Sports

Intervention

Other:
• Ribose
After each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink.
• Placebo

Locations

Country	Name	City	State
Canada	Université Laval	Québec	Quebec

Sponsors (2)

Lead Sponsor	Collaborator
Laval University	Atrium Innovations

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Fatigue perception after each of the 3 consecutive 3km time trials on bike	Post-exercise fatigue perception on visual analog scale (VAS)	baseline and 1 week	No
Other	Peak Vo2 consumption during each of the 3km time trials on bike		baseline and 1 week	No
Primary	Change in time to complete the third of 3 consecutive 3km time trials on bike		baseline and 1 week	No
Secondary	Performance on the 3 consecutive 3km time trials on bike	Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)	baseline and 1 week	No